ClinicalTrials.gov
ClinicalTrials.gov Menu

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00109200
Recruitment Status : Completed
First Posted : April 26, 2005
Last Update Posted : June 21, 2013
Sponsor:
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : September 2003